Clobetasol Propionate NDC 51407-737

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-737Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0737Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-737-25	51407073725	1 BOTTLE in 1 CARTON (51407-737-25) / 25 mL in 1 BOTTLEMarketed from Aug 29, 2023
51407-737-50	51407073750	1 BOTTLE in 1 CARTON (51407-737-50) / 50 mL in 1 BOTTLEMarketed from Aug 29, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clobetasol Propionate
Generic name (nonproprietary): clobetasol propionate
Active ingredients: Clobetasol propionate — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Golden State Medical Supply, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211494
Marketing start: Oct 2, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 51407-737_502865f7-6be4-e587-e063-6294a90acc8aSPL ID 502865f7-6be4-e587-e063-6294a90acc8aSPL set ID 04180cdf-c63a-d524-e063-6394a90a2d06RxCUI 861487UNII 779619577MUPC 0351407737502, 0351407737250
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407073725 followed by a unit qualifier and the quantity

Package 51407-0737-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clobetasol propionate topical solution, USP is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 mL/week because of the potential for the drug to suppress the HPA axis. This product is not recommended for use in pediatric patients under 12 years of age.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211494

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211494
Product	Strength	Form · route	Labeler	Product NDC
Clobetasol Propionate	Clobetasol propionate .5 mg/mL	SolutionTopical	Micro Labs Limited	42571-362
Clobetasol Propionate	Clobetasol propionate .5 mg/mL	SolutionTopical	A-S Medication Solutions	50090-5264